Literature DB >> 24979559

Prevalence of metabolic syndrome in Amol and Zahedan, Iran: a population based study.

Mohammad Reza Ostovaneh1, Farhad Zamani2, Maryam Sharafkhah3, Alireza Ansari-Moghaddam4, Niloofar Akhavan Khaleghi3, Fatemeh Sima Saeedian2, Zohreh Rohani4, Nima Motamed2, Mansoreh Maadi2, Reza Malekzadeh3, Hossein Poustchi3.   

Abstract

PURPOSE: So far, a variety of prevalence rates have been reported for the metabolic syndrome (MetS) according to several definitions. The aim of this study was to assess the prevalence of MetS in Iran according to two definitions and compare the characteristics of the subjects who met the MetS criteria according to the different definitions.
METHODS: Participants were recruited from family registries of public health centers. After obtaining demographic and clinical data, the subjects underwent anthropometric measurements and laboratory evaluations. MetS was defined according to the NCEP-ATPIII and IDF criteria. The subjects were then categorized into 3 groups: 1) Healthy non-MetS subjects based on either definition, 2) Individuals with MetS according to only one of the definitions, and 3) Individuals who met both NCEP-ATPIII and IDF criteria for MetS.
RESULTS: Totally, 5826 subjects in Amol and 2243 subjects in Zahedan were enrolled in the study. The weighted prevalence of MetS according to the NCEP-ATPIII and IDF criteria was 27.8% and 26.9% in Amol and 12% and 11.8% in Zahedan, respectively. Overall, 18.9% of the subjects fulfilled both criteria for MetS. However, a considerable proportion (8.5%) met the MetS criteria according to only one definition but not both.
CONCLUSIONS: MetS is increasingly prevalent in Iran as well as other parts of the world. Due to non-uniform definitions of MetS, some of the subjects who meet MetS according to one set of criteria might be considered healthy according to another definition and consequently would not receive the preventive health services.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24979559     DOI: 0141707/AIM.006

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  9 in total

1.  Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.

Authors:  S R Mirhafez; M Ebrahimi; M Saberi Karimian; A Avan; M Tayefi; A Heidari-Bakavoli; M R Parizadeh; M Moohebati; M R Azarpazhooh; H Esmaily; M Nematy; M Safarian; G A Ferns; M Ghayour-Mobarhan
Journal:  Eur J Clin Nutr       Date:  2016-07-27       Impact factor: 4.016

Review 2.  A Linear Dose-Response Relationship between Fasting Plasma Glucose and Colorectal Cancer Risk: Systematic Review and Meta-analysis.

Authors:  Jianguo Shi; Lijuan Xiong; Jiaoyuan Li; Heng Cao; Wen Jiang; Bo Liu; Xueqin Chen; Cheng Liu; Ke Liu; Guobin Wang; Kailin Cai
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

Review 3.  Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis.

Authors:  Sahar Dalvand; Seyed Hassan Niksima; Reza Meshkani; Reza Ghanei Gheshlagh; Sahar Sadegh-Nejadi; Wesam Kooti; Naser Parizad; Hossein Zahednezhad; Reza Afrisham
Journal:  Iran J Public Health       Date:  2017-04       Impact factor: 1.429

4.  The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.

Authors:  Behnam Rabiee; Farzin Roozafzai; Gholam Reza Hemasi; Hossein Poustchi; Hossein Keyvani; Mahmood Reza Khonsari; Hossein Ajdarkosh; Mansooreh Maadi; Fatemeh Sima Saeedian; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2017-04

5.  Prevalence of metabolic syndrome in Iran: A meta-analysis.

Authors:  Rahim Ostovar; Faezeh Kiani; Fatemeh Sayehmiri; Masood Yasemi; Yazdan Mohsenzadeh; Yousof Mohsenzadeh
Journal:  Electron Physician       Date:  2017-10-25

Review 6.  Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis.

Authors:  Azad Fatahi; Amin Doosti-Irani; Zahra Cheraghi
Journal:  Int J Prev Med       Date:  2020-06-03

7.  The Prevalence and Trend of Metabolic Syndrome in the South-East of Iran.

Authors:  Khadijeh Kalan Farmanfarma; Mahmoud Ali Kaykhaei; Mehdi Mohammadi; Hussein Ali Adineh; Alireza Ansari-Moghaddam
Journal:  J Med Life       Date:  2020 Oct-Dec

Review 8.  Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review.

Authors:  Karimollah Hajian-Tilaki
Journal:  Caspian J Intern Med       Date:  2015

9.  Comparison of the accuracy of three diagnostic criteria and estimating the prevalence of metabolic syndrome: A latent class analysis.

Authors:  Hossein Ebrahimi; Mohammad Hassan Emamian; Ahmad Khosravi; Hassan Hashemi; Akbar Fotouhi
Journal:  J Res Med Sci       Date:  2019-12-23       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.